Rates of hospitalization for respiratory syncytial virus infection among children in medicaid

T G Boyce1, B G Mellen, E F Mitchel

  • 1Department of Pediatric and Adolescent Medicine, Mayo Clinic and Mayo Medical School, Rochester, Minnesota 55905, USA.

The Journal of Pediatrics
|December 13, 2000
PubMed

Insights

Infants with bronchopulmonary dysplasia face high respiratory syncytial virus (RSV) hospitalization rates. Premature infants and those with heart conditions see lower rates after their first year.

Area of Science:

  • Pediatric Infectious Diseases
  • Epidemiology
  • Public Health

Background:

  • Respiratory syncytial virus (RSV) is a common cause of lower respiratory tract infections in infants.
  • Certain medical conditions increase the risk of severe RSV outcomes, including hospitalization.

Purpose of the Study:

  • To determine hospitalization rates for respiratory syncytial virus (RSV) infection in children under three years old.
  • To compare RSV hospitalization rates among children with specific underlying medical conditions versus healthy children.

Main Methods:

  • A retrospective cohort study was conducted using data from the Tennessee Medicaid program.
  • The study included 248,652 child-years of data for children younger than three years old from July 1989 to June 1993.

Main Results:

  • In the first year of life, RSV hospitalization rates per 1000 children were highest for bronchopulmonary dysplasia (388), followed by congenital heart disease (92) and prematurity (70-30, depending on gestational age).
  • In the second year of life, rates decreased but remained elevated for bronchopulmonary dysplasia (73), while congenital heart disease (18) and prematurity (16) showed lower rates.
  • A significant proportion (53%) of RSV hospitalizations occurred in otherwise healthy, full-term infants.

Conclusions:

  • Children with bronchopulmonary dysplasia experience persistently high RSV hospitalization rates up to 24 months of age.
  • After the first year, hospitalization rates for RSV in children with congenital heart disease or prematurity approach those of low-risk infants.
  • These findings highlight the need for targeted RSV prevention strategies for high-risk infants, while also acknowledging the burden of RSV hospitalizations in the general infant population.
Abstract

Related Concept Videos

Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...